These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35844650)

  • 1. Novel Coumarin-Pyridine Hybrids as Potent Multi-Target Directed Ligands Aiming at Symptoms of Alzheimer's Disease.
    Babaei E; Küçükkılınç TT; Jalili-Baleh L; Nadri H; Öz E; Forootanfar H; Hosseinzadeh E; Akbari T; Ardestani MS; Firoozpour L; Foroumadi A; Sharifzadeh M; Mirjalili BBF; Khoobi M
    Front Chem; 2022; 10():895483. PubMed ID: 35844650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of the "hidden" multi-target-directed ligands by AChE/BuChE for the treatment of Alzheimer's disease.
    Chen R; Li X; Chen H; Wang K; Xue T; Mi J; Ban Y; Zhu G; Zhou Y; Dong W; Tang L; Sang Z
    Eur J Med Chem; 2023 May; 251():115253. PubMed ID: 36921526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New phosphazine and phosphazide derivatives as multifunctional ligands targeting acetylcholinesterase and β-Amyloid aggregation for treatment of Alzheimer's disease.
    El-Sayed NF; El-Hussieny M; Ewies EF; Fouad MA; Boulos LS
    Bioorg Chem; 2020 Jan; 95():103499. PubMed ID: 31838287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromone derivatives bearing pyridinium moiety as multi-target-directed ligands against Alzheimer's disease.
    Abdpour S; Jalili-Baleh L; Nadri H; Forootanfar H; Bukhari SNA; Ramazani A; Ebrahimi SES; Foroumadi A; Khoobi M
    Bioorg Chem; 2021 May; 110():104750. PubMed ID: 33691251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease.
    Unzeta M; Esteban G; Bolea I; Fogel WA; Ramsay RR; Youdim MB; Tipton KF; Marco-Contelles J
    Front Neurosci; 2016; 10():205. PubMed ID: 27252617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation.
    Manzoor S; Prajapati SK; Majumdar S; Raza MK; Gabr MT; Kumar S; Pal K; Rashid H; Kumar S; Krishnamurthy S; Hoda N
    Eur J Med Chem; 2021 Apr; 215():113224. PubMed ID: 33582578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel tetrahydroacridine derivatives with iodobenzoic acid moiety as multifunctional acetylcholinesterase inhibitors.
    Skibiński R; Czarnecka K; Girek M; Bilichowski I; Chufarova N; Mikiciuk-Olasik E; Szymański P
    Chem Biol Drug Des; 2018 Feb; 91(2):505-518. PubMed ID: 28944565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and evaluation of novel ferulic acid-O-alkylamine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
    Sang Z; Pan W; Wang K; Ma Q; Yu L; Yang Y; Bai P; Leng C; Xu Q; Li X; Tan Z; Liu W
    Eur J Med Chem; 2017 Apr; 130():379-392. PubMed ID: 28279845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
    Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
    Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromone-lipoic acid conjugate: Neuroprotective agent having acceptable butyrylcholinesterase inhibition, antioxidant and copper-chelation activities.
    Jalili-Baleh L; Nadri H; Forootanfar H; Küçükkılınç TT; Ayazgök B; Sharifzadeh M; Rahimifard M; Baeeri M; Abdollahi M; Foroumadi A; Khoobi M
    Daru; 2021 Jun; 29(1):23-38. PubMed ID: 33420969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of novel coumarin derivatives as multifunctional ligands for the treatment of Alzheimer's disease.
    Liu W; Wu L; Liu W; Tian L; Chen H; Wu Z; Wang N; Liu X; Qiu J; Feng X; Xu Z; Jiang X; Zhao Q
    Eur J Med Chem; 2022 Nov; 242():114689. PubMed ID: 36007469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
    Zhu J; Yang H; Chen Y; Lin H; Li Q; Mo J; Bian Y; Pei Y; Sun H
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):496-506. PubMed ID: 29405075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New classes of carbazoles as potential multi-functional anti-Alzheimer's agents.
    Choubdar N; Golshani M; Jalili-Baleh L; Nadri H; Küçükkilinç TT; Ayazgök B; Moradi A; Moghadam FH; Abdolahi Z; Ameri A; Salehian F; Foroumadi A; Khoobi M
    Bioorg Chem; 2019 Oct; 91():103164. PubMed ID: 31398601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids.
    Bautista-Aguilera OM; Esteban G; Chioua M; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Soriano E; Samadi A; Unzeta M; Marco-Contelles J
    Drug Des Devel Ther; 2014; 8():1893-910. PubMed ID: 25378907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, biological evaluation and molecular docking study of novel piperidine and piperazine derivatives as multi-targeted agents to treat Alzheimer's disease.
    Meena P; Nemaysh V; Khatri M; Manral A; Luthra PM; Tiwari M
    Bioorg Med Chem; 2015 Mar; 23(5):1135-48. PubMed ID: 25624107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of New 3-Arylcoumarins Bearing
    Pourabdi L; Küçükkılınç TT; Khoshtale F; Ayazgök B; Nadri H; Farokhi Alashti F; Forootanfar H; Akbari T; Shafiei M; Foroumadi A; Sharifzadeh M; Shafiee Ardestani M; Abaee MS; Firoozpour L; Khoobi M; Mojtahedi MM
    Front Chem; 2021; 9():810233. PubMed ID: 35127652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of Alzheimer's disease.
    Brunetti L; Leuci R; Carrieri A; Catto M; Occhineri S; Vinci G; Gambacorta L; Baltrukevich H; Chaves S; Laghezza A; Altomare CD; Tortorella P; Santos MA; Loiodice F; Piemontese L
    Eur J Med Chem; 2022 Jul; 237():114358. PubMed ID: 35462163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Cyclopentaquinoline and Acridine Analogs as Multifunctional, Potent Drug Candidates in Alzheimer's Disease.
    Maciejewska K; Czarnecka K; Kręcisz P; Niedziałek D; Wieczorek G; Skibiński R; Szymański P
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel series of 2-substituted benzo[d]oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer's disease.
    Gutti G; Kakarla R; Kumar D; Beohar M; Ganeshpurkar A; Kumar A; Krishnamurthy S; Singh SK
    Eur J Med Chem; 2019 Nov; 182():111613. PubMed ID: 31437780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Novel Pyrazolopyrimidinone Derivatives as Phosphodiesterase 9A Inhibitors Capable of Inhibiting Butyrylcholinesterase for Treatment of Alzheimer's Disease.
    Yu YF; Huang YD; Zhang C; Wu XN; Zhou Q; Wu D; Wu Y; Luo HB
    ACS Chem Neurosci; 2017 Nov; 8(11):2522-2534. PubMed ID: 28783948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.